Adenylyl cyclase (AC) catalyzes the conversion of ATP to cAMP. The activation of receptors for neurotransmitters and hormones which are coupled to the stimulatory and inhibitory GTP binding proteins of AC, G(s) and G(j), respectively, either stimulate or inhibit AC. The resulting alterations in cAMP levels then modulate the activity of cAMP- dependent protein kinase (PKA), or other proteins that bind cAMP, to elicit a number of biological actions. The predominant forms of AC in the heart are the type V (ACV) and type VI (ACVI) isoforms. Recently, we showed that the two cytoplasmic domains, C1 and C2, of ACV can increase the ability of receptor coupled to G(j) and G(s), respectively, to modulate AC activity. Additionally, the C2 domain of ACV acts as a GTPase activating protein (GAP) for G(s-alpha). Moreover, we have identified a novel protein, PAM, as a potent inhibitor of several isoforms of AC. Therefore, the overall objectives of this proposal are to identify the mechanisms and molecular interactions involved in the novel functions of AC, to elucidate the mechanisms involved in inhibition of AC by PAM, and to determine the role of PAM in modulating AC activity in intact cells.
The specific aims of this application are (1) to elucidate the mechanisms by which the C2 and C1 domains of ACV enhance the GEF activity of G(s)- and G(j)- coupled receptors, respectively. (2) To determine whether mutations of one or more residues on alpha3-beta5 loop and/or in switch II regions of G(s- alpha), which contact the C2 domain of AC, alter the ability of ACV and its C2 domain to (i) act as G(s-alpha) -GAPs, and (ii) enhance the GEF activity of G(s) coupled receptors. (3) To investigate if PAM interacts with AC and inhibits cAMP accumulation in intact cells. (4) To determine whether PAM interferes with the ability of ACV and its C2 domain to act as a G(s-alpha)-GAP and augment the onset of signals via G(s) coupled receptors. Alterations in cAMP levels regulate an array of biological actions ranging from heart rate and contractility to learning, long-term memory and endocrine function. Therefore, the elucidation of the mechanisms involved in the modulation of G protein activity by ACV will have profound implications in our understanding of the regulation of a variety of physiological and pathophysiological processes involving cAMP as a second messenger. Likewise, presently, the only biological function that can be assigned to PAM is that it is a novel and potent inhibitor of AC. Thus the elucidation of the role of PAM in modulating AC activity in intact cells and the mechanisms of its action will provide new insights into how AC activity can be regulated.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059679-08
Application #
6683185
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Buxton, Denis B
Project Start
1997-12-08
Project End
2005-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
8
Fiscal Year
2004
Total Cost
$296,000
Indirect Cost
Name
Loyola University Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
791277940
City
Maywood
State
IL
Country
United States
Zip Code
60153
Gao, Xianlong; Sadana, Rachna; Dessauer, Carmen W et al. (2007) Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits. J Biol Chem 282:294-302
Ongur, Dost; Pohlman, Jessica; Dow, Antonia L et al. (2007) Electroconvulsive seizures stimulate glial proliferation and reduce expression of Sprouty2 within the prefrontal cortex of rats. Biol Psychiatry 62:505-12
Edwin, Francis; Singh, Rakesh; Endersby, Raelene et al. (2006) The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation. J Biol Chem 281:4816-22
Edwin, Francis; Wiepz, Gregory J; Singh, Rakesh et al. (2006) A historical perspective of the EGF receptor and related systems. Methods Mol Biol 327:1-24
Wiepz, Gregory J; Edwin, Francis; Patel, Tarun et al. (2006) Methods for determining the proliferation of cells in response to EGFR ligands. Methods Mol Biol 327:179-87
Chaturvedi, Deepti; Poppleton, Helen M; Stringfield, Teresa et al. (2006) Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase. Mol Cell Biol 26:4586-600
Di Cesare Mannelli, Lorenzo; Pacini, Alessandra; Toscano, Annarita et al. (2006) A recombinant transductor-effector system: in vitro study of G inhibitory protein (G-alpha-i1) direct activators. Arch Biochem Biophys 453:151-60
Gao, Xianlong; Patel, Tarun B (2005) Histidine residues 912 and 913 in protein associated with Myc are necessary for the inhibition of adenylyl cyclase activity. Mol Pharmacol 67:42-9
Gao, Xianlong; Du, Ziyun; Patel, Tarun B (2005) Copper and zinc inhibit Galphas function: a nucleotide-free state of Galphas induced by Cu2+ and Zn2+. J Biol Chem 280:2579-86
Patel, Tarun B (2004) Single transmembrane spanning heterotrimeric g protein-coupled receptors and their signaling cascades. Pharmacol Rev 56:371-85

Showing the most recent 10 out of 18 publications